Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srijanee Das

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Communications Biology|July 30, 2024
Development of an extended action fostemsavir lipid nanoparticleFarhana Islam, Srijanee Das, Md Ashaduzzaman, et al.
Biomolecules|August 26, 2023
Chronic Hepatitis B Infection: New Approaches towards CureMojisola Ogunnaike, Srijanee Das, Samiksha S Raut, et al.
Advanced Drug Delivery Reviews|July 14, 2023
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infectionMohammad Ullah Nayan, Brady Sillman, Mahmudul Hasan, et al.
Research Square|March 4, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic TailBenson Edagwa, Mohammad Ullah Nayan, Brady Sillman, et al.
Science Advances|December 23, 2022
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppressionSrijanee Das, Weimin Wang, Murali Ganesan, et al.
Nature Communications|January 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tailMohammad Ullah Nayan, Brady Sillman, Srijanee Das, et al.
Science Advances|August 1, 2025
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppressionSamiksha S Raut, Srijanee Das, Grace Bybee, et al.
FEMS Microbiology Reviews|June 23, 2021
The Immunopathobiology of SARS-CoV-2 InfectionMilankumar Patel, Farah Shahjin, Jacob D Cohen, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|January 6, 2021
Pharmacotherapeutics of SARS-CoV-2 InfectionsBhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, et al.
Nature Materials|February 16, 2021
Diagnostics for SARS-CoV-2 infectionsBhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Communications Biology|July 30, 2024
Development of an extended action fostemsavir lipid nanoparticleFarhana Islam, Srijanee Das, Md Ashaduzzaman, et al.
Biomolecules|August 26, 2023
Chronic Hepatitis B Infection: New Approaches towards CureMojisola Ogunnaike, Srijanee Das, Samiksha S Raut, et al.
Advanced Drug Delivery Reviews|July 14, 2023
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infectionMohammad Ullah Nayan, Brady Sillman, Mahmudul Hasan, et al.
Research Square|March 4, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic TailBenson Edagwa, Mohammad Ullah Nayan, Brady Sillman, et al.
Science Advances|December 23, 2022
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppressionSrijanee Das, Weimin Wang, Murali Ganesan, et al.
Nature Communications|January 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tailMohammad Ullah Nayan, Brady Sillman, Srijanee Das, et al.
Science Advances|August 1, 2025
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppressionSamiksha S Raut, Srijanee Das, Grace Bybee, et al.
FEMS Microbiology Reviews|June 23, 2021
The Immunopathobiology of SARS-CoV-2 InfectionMilankumar Patel, Farah Shahjin, Jacob D Cohen, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|January 6, 2021
Pharmacotherapeutics of SARS-CoV-2 InfectionsBhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, et al.
Nature Materials|February 16, 2021
Diagnostics for SARS-CoV-2 infectionsBhavesh D Kevadiya, Jatin Machhi, Jonathan Herskovitz, et al.
Pageof 2